GOSS
Gossamer Bio Inc
NASDAQ: GOSS · HEALTHCARE · BIOTECHNOLOGY
$0.37
+5.21% today
Updated 2026-04-30
Market cap
$81.79M
P/E ratio
—
P/S ratio
1.69x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$0 – $4
Volume
18.7M
WallStSmart proprietary scores
41
out of 100
Grade: D
Sell
Investment rating
6.3
Growth
B5.0
Quality
C+2.5
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$3.69
+902.18%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy2 Buy5 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 47.10% QoQ
Risks
- Thin margins at 0.00%
- Negative free cash flow $-48.31M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $114.70M | $48.47M | $48.47M |
| Net income | $-229.38M | $-179.82M | $-56.53M | $-170.37M | $-47.24M |
| EPS | — | — | — | — | $-0.75 |
| Free cash flow | $-187.51M | $-159.16M | $-3.47M | $-171.34M | $-48.31M |
| Profit margin | — | — | -49.28% | -351.49% | — |
Peer comparison
Smart narrative
Gossamer Bio Inc trades at $0.37. Our Smart Value Score of 41/100 indicates the stock is fair. TTM revenue stands at $48.47M.
Frequently asked questions
What is Gossamer Bio Inc's stock price?
Gossamer Bio Inc (GOSS) trades at $0.37.
Is Gossamer Bio Inc overvalued?
Smart Value Score 41/100 (Grade D, Sell).
What is the price target of Gossamer Bio Inc (GOSS)?
The analyst target price is $3.69, representing +902.2% upside from the current price of $0.37.
What is Gossamer Bio Inc's revenue?
TTM revenue is $48.47M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.69x
ROE-783.00%
Beta2.16
50D MA$0.59
200D MA$2.09
Shares out0.23B
Float0.21B
Short ratio—
Avg volume18.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—